These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36442364)

  • 1. Are patients with Parkinson's disease at a lower risk of catching the common cold? Propensity score matching.
    Neshige S; Aoki S; Nezu T; Nakamori M; Yamazaki Y; Ohshita T; Maruyama H
    Parkinsonism Relat Disord; 2023 Jan; 106():105227. PubMed ID: 36442364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
    Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of cerebrospinal fluid α-synuclein and the tau/α-synuclein ratio for diagnosis of neurodegenerative disorders with Lewy pathology.
    Førland MG; Tysnes OB; Aarsland D; Maple-Grødem J; Pedersen KF; Alves G; Lange J
    Eur J Neurol; 2020 Jan; 27(1):43-50. PubMed ID: 31293044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migraine is related to an increased risk of Parkinson's disease: A population-based, propensity score-matched, longitudinal follow-up study.
    Wang HI; Ho YC; Huang YP; Pan SL
    Cephalalgia; 2016 Dec; 36(14):1316-1323. PubMed ID: 26853806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Syndrome and Parkinson's Disease Incidence: A Nationwide Study Using Propensity Score Matching.
    Roh JH; Lee S; Yoon JH
    Metab Syndr Relat Disord; 2021 Feb; 19(1):1-7. PubMed ID: 32876524
    [No Abstract]   [Full Text] [Related]  

  • 7. Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related alpha-synucleinopathies.
    Muntané G; Dalfó E; Martinez A; Ferrer I
    Neuroscience; 2008 Apr; 152(4):913-23. PubMed ID: 18343584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases.
    Williams SM; Schulz P; Sierks MR
    Eur J Neurosci; 2016 Jan; 43(1):3-16. PubMed ID: 26332448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease is related to an increased risk of ischemic stroke-a population-based propensity score-matched follow-up study.
    Huang YP; Chen LS; Yen MF; Fann CY; Chiu YH; Chen HH; Pan SL
    PLoS One; 2013; 8(9):e68314. PubMed ID: 24023710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excess deaths from Alzheimer's disease and Parkinson's disease during the COVID-19 pandemic in the USA.
    Li S; Han L; Shi H; Chong MKC; Zhao S; Ran J
    Age Ageing; 2022 Dec; 51(12):. PubMed ID: 36571781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia.
    Chiasserini D; Biscetti L; Eusebi P; Salvadori N; Frattini G; Simoni S; De Roeck N; Tambasco N; Stoops E; Vanderstichele H; Engelborghs S; Mollenhauer B; Calabresi P; Parnetti L
    Alzheimers Res Ther; 2017 Jul; 9(1):52. PubMed ID: 28750675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal Fluid Biomarkers in Highly Exposed PM2.5 Urbanites: The Risk of Alzheimer's and Parkinson's Diseases in Young Mexico City Residents.
    Calderón-Garcidueñas L; Avila-Ramírez J; Calderón-Garcidueñas A; González-Heredia T; Acuña-Ayala H; Chao CK; Thompson C; Ruiz-Ramos R; Cortés-González V; Martínez-Martínez L; García-Pérez MA; Reis J; Mukherjee PS; Torres-Jardón R; Lachmann I
    J Alzheimers Dis; 2016 Sep; 54(2):597-613. PubMed ID: 27567860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
    Orimo S
    Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of plasma biomarkers to pathologies in Alzheimer's disease, Parkinson's disease and frontotemporal dementia.
    Chiu PY; Yang FC; Chiu MJ; Lin WC; Lu CH; Yang SY
    Sci Rep; 2022 Oct; 12(1):17919. PubMed ID: 36289355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of salusins with Parkinson's Disease, Alzheimer's Disease, and acute ischemic stroke: A preliminary study.
    Çakır M; Saçmacı H
    Neurosci Lett; 2024 Feb; 824():137683. PubMed ID: 38350537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid alpha-synuclein as a biomarker for Parkinson's disease diagnosis: a systematic review and meta-analysis.
    Gao L; Tang H; Nie K; Wang L; Zhao J; Gan R; Huang J; Zhu R; Feng S; Duan Z; Zhang Y; Wang L
    Int J Neurosci; 2015; 125(9):645-54. PubMed ID: 25202803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Links between COVID-19 and Parkinson's disease/Alzheimer's disease: reciprocal impacts, medical care strategies and underlying mechanisms.
    Huang P; Zhang LY; Tan YY; Chen SD
    Transl Neurodegener; 2023 Jan; 12(1):5. PubMed ID: 36717892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of age-related changes in psychosine metabolism in the human brain.
    Marshall MS; Jakubauskas B; Bogue W; Stoskute M; Hauck Z; Rue E; Nichols M; DiAntonio LL; van Breemen RB; Kordower JH; Saavedra-Matiz CA; Bongarzone ER
    PLoS One; 2018; 13(2):e0193438. PubMed ID: 29481565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated Plasma and Neuroimaging Biomarkers Associated with Motor and Cognition Severity in Parkinson's Disease.
    Chen CH; Lee BC; Lin CH
    J Parkinsons Dis; 2020; 10(1):77-88. PubMed ID: 31868681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-Synuclein mRNA and soluble α-synuclein protein levels in post-mortem brain from patients with Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease.
    Quinn JG; Coulson DT; Brockbank S; Beyer N; Ravid R; Hellemans J; Irvine GB; Johnston JA
    Brain Res; 2012 Jun; 1459():71-80. PubMed ID: 22560502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.